BNL blue star helium limited

9.09%

0.5¢

Ann: General Meeting Resolutions, page-21

First 21 Last

Share
Profile

Follow
Footmax

15,570 Posts.

2787

26/01/22

12:30

Post #: 59138811
Share

Totally agree.

Especially when you think that the so called incentives are just things that a OD should be achieving through normal operations.

Staggers me that shareholders across the board on the ASX just let them go through without questioning them.

Originally posted by Sweetsound: ↑

In all the years of investing I'm still baffled at how publicly listed companies allow the kind of giving to some at the top of the food chain. What sort of a racket is it when the very shareholders supporting a company with cr's etc, continually see a large part of funds simply given to directors in terms of shares based performance or any other incentive favoring them and yet the very givers have their share value in negative territory.

It is also hardly fair to offer incentives simply based on a structured increase of share price from a low base. Increasing a near zero sp to double value may not be that hard thus hardly justifies all bonuses offered.

Most places have a salary or wage based system that is fixed - irrespective of how much or how little a company makes. If a company does well the rewards are your salary and/or wages and perhaps by a generous boss distributing a bonus to all concerned perhaps at year end and of course, keeping your job. In the event of poor company earnings, someone loses their job and if at company level massive losses ensue, the place may just simply permanently shut.

All directors are handsomely remunerated in the first instance - there should be no additional bonuses of any kind - except to say they have the same rights to buy shares in the company from the money they earn - incentive for them to earn their keep and let all prosper.

The skewed level playing field may never be level but a little more so and the term 'shareholder value' may actually have a bit more truth to it.

What a racket - the kind of racket that tennis players would sure have a winning shot with.

Expand

BNL Price at posting: 4.4¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 21 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change -0.001(9.09%)		Mkt cap ! $13.47M

Open	High	Low	Value	Volume
0.5¢	0.6¢	0.5¢	$45.15K	9.007M

Buyers (Bids)

No.	Vol.	Price($)
2	514861	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	3604481	9

View Market Depth

No.	Vol.	Price($)
2	514861	0.005
28	23151160	0.004
9	15476669	0.003
6	20032500	0.002
5	29805000	0.001

Price($)	Vol.	No.
0.006	3604481	9
0.007	6906658	15
0.008	12112729	27
0.009	4080033	12
0.010	3618005	6

Last trade - 15.25pm 27/06/2025 (20 minute delay)

BNL (ASX) Chart

Ann: General Meeting Resolutions, page-21

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: General Meeting Resolutions, page-21

Top Stories

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News